In order to better evaluate drug anti-tumor activity, it is essential to have a method that can help track tumor growth and quantify tumor burden in vivo easily. Biocytogen has created a list of luciferase-labeled cell lines for tumor model generation and bioluminescence imaging in live animal models, providing simpler, highly sensitive, robust means for tumor measurement and in vivo drug efficacy studies.
| Product | Disease | Organism | Culture Type |
|---|---|---|---|
| B-Luciferase 4T1 Cell Line | Breast carcinoma | Murine | Adherent |
| B-Luciferase B16-F10 Cell Line | Melanoma | Murine | Adherent |
| B-Luciferase EL4 Cell Line | Lymphoma | Mouse | Suspension |
| B-Luciferase Hep3B2.1-7 Cell Line | Hepatocellular carcinoma | Human | Adherent |
| B-Luciferase Hepa 1-6 Cell Line | Hepatoma | Mouse | Adherent |
| B-Luciferase K562 Cell Line | Leukemia (CML) | Human | Suspension |
| B-Luciferase MIA PaCa-2 Cell Line | Pancreatic carcinoma | Human | Adherent |
| B-Luciferase U87-MG Cell Line | Glioblastoma | Human | Adherent |
| B-Luciferase-GFP HT-29 Cell Line | Colorectal adenocarcinoma | Human | Adherent |
| B-Luciferase-GFP NCI-H1975 Cell Line | Adenocarcinoma; nonsmall cell lung cancer | Human | Adherent |
| B-Luciferase-GFP Raji Cell Line | Lymphoma, Burkitt’s | Human | Suspension |
Our humanized tumor cell lines are for pharmacology services only.
